Key Takeaways
- Google's AMIE chatbot consulted 98 patients before urgent primary care visits in a study published in The Lancet on Oct. 8, 2026.
- Supervising physicians watched the chats live, and no conversation needed a safety stop under the study's criteria.
- AMIE's differential diagnoses matched the doctors' final diagnoses 90% of the time, according to Google.
On Oct. 8, 2026, The Lancet published a study of Google's AMIE chatbot at the primary care clinic of Beth Israel Deaconess Medical Center in Boston. In the study, 98 patients consulted AMIE before urgent care visits, and supervising physicians monitored each chat in real time.
Google calls AMIE "our research diagnostic AI chatbot." The company says the paper is its first-ever publication in the main journal of The Lancet, and it describes the study as a real-world test of a conversational diagnostic tool in a clinic that sees urgent patients.
Google AMIE Chats: How Supervision Worked in the Study
Google's post says that supervising physicians "monitored the interactions in real time, and not a single conversation needed to be interrupted based on predefined safety criteria." Unite.ai, citing a Beth Israel Deaconess Medical Center release dated Oct. 9, 2026, reports that each conversation was watched live by a board-certified internal medicine physician over a video call with screen sharing.
Unite.ai says the supervisors were trained to step in under four criteria: immediate concern for harm to self or others, significant emotional distress related to the AI interaction, potential clinical harm that a supervisor identifies, or an explicit patient request to end the session. The hospital said the study ran from April through November 2025.
Across all 98 completed encounters, no conversation required a safety stop. Supervising physicians identified one hallucination and gave additional clinical clarification in five cases, according to the same account. Google also reported that clinicians said the AI summaries helped them prepare for visits in 75% of cases, and that the summaries influenced their approach to care in more than half.
Google AMIE Enrollment: 114 Patients, 98 Completed Encounters
The hospital enrolled 114 patients, according to Unite.ai's account of its release. Only 98 completed encounters, which leaves 16 patients, or 14% of the enrolled group, without a completed encounter. Google's post mentions only the 98 patients who consulted AMIE, and neither the company's post nor the hospital account, as Unite.ai relays it, explains what happened to those 16. Readers comparing the study with other reports should use 98 completed encounters and treat 114 as the enrollment base.
Peter Brodeur, a co-first author and clinical fellow in cardiovascular medicine at the hospital, said in the release: "This study helps establish the baseline characteristics of such real-world conversations." The hospital says it believes the study is the first prospective real-world study of a patient-facing conversational AI system in primary care.
Google AMIE Next Steps: Why One Clinic Limits the Findings
Google says larger clinical trials are needed to assess patient-facing AI at scale. That caveat matters because the study ran at one primary care clinic in Boston, so its results describe that setting. The study does not show how the same chatbot would perform in other clinics, with other patient populations, or over longer periods. Unite.ai reports that Google's announcement says the findings suggest potential for AI to enhance the patient-physician relationship and ease strain on healthcare workers.
People Also Ask
Did Google's AMIE chatbot need any safety stops in the Lancet study?
No safety stop was needed in the 98 completed encounters at Beth Israel Deaconess Medical Center, according to the hospital release as Unite.ai reports it. Supervising physicians identified one hallucination and gave extra clinical clarification in five cases.
How many patients did Google's AMIE study at Beth Israel Deaconess enroll?
The hospital enrolled 114 patients, and 98 of them completed encounters with Google's AMIE chatbot, according to Unite.ai's account of the hospital release. Google's own post says 98 patients consulted AMIE before urgent care visits.
What is Google's AMIE chatbot?
Google describes AMIE as "our research diagnostic AI chatbot." In the Lancet study, AMIE's differential diagnoses matched the doctors' final diagnoses 90% of the time, according to Google.
Is Google's AMIE chatbot ready for patients to use?
Google says larger clinical trials are needed to assess patient-facing AI at scale. The Lancet study took place at one primary care clinic in Boston, so its results describe that setting.